Syndax Pharmaceuticals SNDX Customer Collateral Assets
Customer Collateral Assets at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DepositsAssetsCurrent.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's customer collateral assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's customer collateral assets?
- Syndax Pharmaceuticals (SNDX) reported customer collateral assets of $9.18M in Q1 2026.
- How has Syndax Pharmaceuticals's customer collateral assets changed year-over-year?
- Syndax Pharmaceuticals's customer collateral assets increased by 122.9% year-over-year, from $4.12M to $9.18M.
- What is the long-term trend for Syndax Pharmaceuticals's customer collateral assets?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's customer collateral assets has grown at a 29.9% compound annual growth rate (CAGR), from $6.89M to $19.62M.
- What does customer collateral assets mean?
- This represents assets held as security or collateral provided by customers to mitigate credit risk in commercial transactions. It reflects the company's exposure to counterparty default and the effectiveness of its credit risk management policies. Monitoring this balance helps investors assess the security of receivables and the overall credit quality of the customer base.